Imagene AI is democratizing precision medicine with multi-modal foundation models and an end-to-end OI Suite. At the core of our technology is a Living Intelligence Engine that continuously integrates and learns from imaging, molecular, and clinical data, making every clinical trial more responsive, every insight more actionable, and every patient journey more personalized.
Our OI Suite is a transformative platform that empowers researchers, clinicians, and pharmaceutical partners across the full spectrum of oncology innovation, from biomarker discovery to patient identification. Our first product, LungOI, is an AI-powered multi-gene test for NSCLC that rapidly profiles biomarkers directly from a standard biopsy image, enabling faster and more informed clinical decisions.
Powered by our state-of-the-art multimodal foundation models- trained on over 1.5 million tissue samples from more than 40 organs and tissue types, along with diverse biological modalities-Imagene AI enables cutting-edge research, especially in data-limited settings.
We are committed to advancing precision medicine and expanding its impact across cancer and beyond. If you are passionate about transforming patient care through AI and innovation, we invite you to join us on this meaningful journey.
We are seeking a highly motivated, entrepreneurial, and results-driven Head of Business Development to lead and expand strategic partnerships with pharmaceutical and biotechnology organizations. This role will be responsible for driving revenue growth, developing long-term strategic relationships, and positioning Imagene's AI-powered solutions as a critical enabler of drug development, translational research, precision medicine, and commercial programs.
The successful candidate will work closely with pharmaceutical and biotech partners across Translational Medicine, Precision Medicine, Clinical Development, Commercial, and Research functions, while collaborating internally with Medical Affairs, Product, Operations, and Scientific teams to advance client programs and maximize the impact of Imagene's technology platform.